Skip to content

Evaluation of body composition of inflammatory bowel disease using high accuracy body composition analyzer

Evaluation of body composition of inflammatory bowel disease using high accuracy body composition analyzer - IBD and body composition

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000029520
Enrollment
800
Registered
2017-10-12
Start date
2017-10-12
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

inflammatory bowel disease

Interventions

None listed

Sponsors

Shiga University of Medical Science
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients with inflammatory bowel disease in hospitalized or outpatient settings

Exclusion criteria

Exclusion criteria: Patients with pacemakers pregnant women patients who cannot obtain consent Patients who the doctor considers inappropriate

Design outcomes

Primary

MeasureTime frame
Correlation between muscle mass and grip strength and disease activity of inflammatory bowel disease

Countries

Japan

Contacts

Public ContactShigeki Bamba

Shiga University of Medical Science Division of Gastroenterology

sb@belle.shiga-med.ac.jp077-548-2217

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026